This infographic describes the global spending on non-communicable diseases by country, channel, and program area.
This infographic describes DAH spending by the US through 2019.
This infographic describes DAH spending by the UK through 2019.
Universal mask use could save nearly 250,000 lives globally. View reported mask use by WHO region, including countries with the highest and lowest reported rates.
Wear a mask whenever you are in public to help curb the spread of COVID-19, and encourage others to do the same. Widespread mask use may temper or even help prevent a second wave of the pandemic.
To address the growing threat of antimicrobial resistance (AMR), leaders in global health research came together to create the Global Research on Antimicrobial Resistance (GRAM) Project, a partnership between IHME and the University of Oxford.
To estimate the global burden of AMR we are seeking anonymised, non-identifiable data from 1990 onward, including patient-level microbiology data, clinical records, and patient outcomes.
By analyzing the distance to health facilities in areas at risk of outbreaks of infectious diseases, the Institute for Health Metrics and Evaluation has created a framework that shows how travel time can affect the spread of viral hemorrhagic fevers during an outbreak and how this information can help inform efforts to strengthen health systems.
Burns and other injuries caused by exposure to fire, heat, and hot substances can cause severe disability and death, even when health care services are available. Among the world’s regions, substantial variation exists in both the number of cases of these injuries and the rates of death resulting from them.
This Visualizing Health Metrics infographic, based on estimates from the Global Burden of Disease 2017 Study, features global patterns in prevalence of and deaths attributable to type 2 diabetes from 2007 through 2017.
A new study from IHME and its collaborators worldwide looks at how a child’s chance of dying before age 5 depends on where they live. When it comes to saving children’s lives, we have a lot of evidence about what works. Building on that strong foundation, these district-level maps are a helpful addition to policymakers’ toolkit, as they highlight places that have been left behind and require more attention.
The extraordinary resources invested to fight HIV/AIDS in low- and middle-income countries ($221 billion from 2000 to 2016) have helped change the course of history. This infographic highlights findings from the first long-term and comprehensive analysis of funding for HIV/AIDS.
Dr. Richard Horton, the “activist editor” of the international medical journal The Lancet, is receiving the Roux Prize, given annually to individuals on the front lines of global health innovation in data science.
HIV/AIDS remains the most common cause of death in sub-Saharan Africa. As of 2017, 71% of the world’s HIV-positive population lived there. Before this study, differences in subnational HIV prevalence (the percentage of people with HIV) and the number of people living with HIV (PLHIV) had not been examined comprehensively across sub-Saharan Africa at high spatial resolution.
In 2016, a total of $4.3 billion was spent globally on malaria, which includes funding from all sources: donor, government, out-of-pocket, and prepaid private sources. Still, spending fell short of the annual funding target set by WHO to control or eliminate malaria by 2020.
Healthier diets could save one in five lives every year. Poor diet causes more deaths than any other risk factor. Most diet-related deaths are caused by eating too much sodium and not enough whole grains and fruit.
IHME needs help in assembling a comprehensive database of the world’s geolocated health data.
Everyone, all over the world, deserves to live a long life in full health. The Global Burden of Disease study measures what prevents us from achieving that goal.
“Lifetime stroke risk” is the probability of a person developing a stroke at some point during their remaining lifespan, after accounting for other risks of death.
“Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990– 2017: a systematic analysis for the Global Burden of Disease Study 2017” is based on more data than ever before. Nineteen new causes were added for a total of 359 causes. The study also includes a more detailed analysis of healthy life expectancy.
“Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017” is based on more data than ever before and includes 68,781 data sources used for the analysis of nonfatal causes of disease and injury. GBD 2017 added 19 new causes to its nonfatal analysis, for a total of 354 causes. The study includes a more detailed analysis of disability than previous versions of GBD.
“Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017” is based on more data than ever before and includes 622 new data sources, for a total of 8,259 data sources. The 2017 study produced and used a new set of population estimates, which has led to substantial changes in mortality estimates in many countries. The analysis has been extended in time by two decades to start in 1950, and the statistical methods have been improved.
“Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017” estimated mortality for 282 causes of death in 195 countries from 1980 to 2017, adding 18 causes to its estimates compared to GBD 2016. In 2017, the GBD study added numerous data sources, including 127 country-years of vital registration data and 502 country-years of cancer registry data.
This update to the Global Burden of Diseases, Injuries, and Risk Factors study (GBD) includes an important new feature: for the first time, population and fertility estimates were produced by the GBD collaborators. Those estimates confirm and extend our understanding of key population trends, including those related to health.